跳至主要内容
临床试验/NCT05281042
NCT05281042已完成不适用

Home OCT Repeatability and Reproducibility of Automatic Fluid Quantification Study

Notal Vision Inc.1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2021年9月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
20
试验地点
1
主要终点
Zeiss Cirrus OCT Intra-Retinal Fluid (IRF) amount measured by a human reader

研究概览

简要总结

The study will enroll up to 30 AMD patients diagnosed with NV-AMD in at least one eye at the time of enrollment. At the Study Visit, fluid must be present in at least one eye of the subjects. If only one eye qualifies for enrollment, that will be assigned as the study eye. If both eyes are eligible, the study eye will be assigned according to a randomization schedule. Only one eye of each subject will be enrolled in the study. All subjects will be enrolled at 1 site in the United States. Subjects must meet all inclusion and no exclusion criteria.

详细描述

Description of Study Procedures and In-Office Visit:

Enrollment/Screening:

At the Enrollment/ Screening Visit, the exams will be conducted in the following order:

  1. Patient will be informed concerning the study and sign the Informed Consent Form (ICF) prior to conduct of any study procedures.

  2. The following data will be collected for each study subject:

  3. Subject's DOB

  4. Gender

  5. Number and type of injections and last injection date

  6. The following data will be collected for the study eye:

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Ability to speak, read and understand English.
  • •Ability to understand and agree to contents of informed consent in writing or verbal.
  • •Adult diagnosed with NV-AMD in at least one eye based on the subject's medical record.
  • •Fluid presence in the study eye per the PI review of Screening commercial OCT.
  • •Best corrected Visual Acuity of 20/320 or better in the study eye.
  • •Available and willing to conduct self-scanning in the office

排除标准

  • •Any other retinal disease requiring steroidal or anti-VEGF injections.
  • •Dilated pupils

结局指标

主要结局

Zeiss Cirrus OCT Intra-Retinal Fluid (IRF) amount measured by a human reader

时间窗: 5 minutes

volume \[nl\] of the IRF

Notal Home OCT Sub-Retinal Fluid (SRF) amount measured by NOA

时间窗: 5 minutes

volume \[nl\] of the SRF

Zeiss Cirrus OCT Sub-Retinal Fluid (SRF) amount measured by a human reader

时间窗: 5 minutes

volume \[nl\] of the SRF

Notal Home OCT Intra-Retinal Fluid (IRF) amount measured by NOA

时间窗: 5 minutes

volume \[nl\] of the IRF

Zeiss Cirrus OCT Total Retinal Fluid (TRF) amount measured by a human reader

时间窗: 5 minutes

volume \[nl\] of the TRF

Notal Home OCT Total Retinal Fluid (TRF) amount measured by NOA

时间窗: 5 minutes

volume \[nl\] of the TRF

次要结局

  • Subjects who completed self-scanning on the Notal Home OCT, following a self-tutorial.(5 minuts)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Home OCT Repeatability and Reproducibility of... | 临床试验